Iron 65 mg
Product analysis
AI assessment of the formula, label and price. How scoring works
Nutrient Quality40
Ingredient Transparency100
Value For Money100
Customer Satisfaction73
Product Focus62
- Format
Tablet - Container
- 240 Tablet(s)
- Per serving
- $0.04
- Also available
Iron 65 mg$5.65- Customer rating
- 4.7 · 220 ratings
Goals
Iron 65 mg is relevant to energy when iron deficiency contributes to fatigue, rather than as an everyday energizer. Its selected serving supplies 65 mg iron as ferrous sulfate. That is a substantial iron amount, so the practical fit depends on a demonstrated need for iron replacement.
Iron 65 mg has a specific hair-health role when confirmed iron deficiency contributes to shedding. The 65 mg serving provides a substantial iron amount, but the appropriate replacement amount depends on individual iron status rather than a general hair-health goal.
Iron 65 mg is a targeted nutrient product with an immunity benefit that depends on correcting low iron. Its 65 mg ferrous sulfate serving is not a routine immune choice, because extra iron can be unsuitable in some infection settings. Iron helps restore immune-cell function when deficiency has impaired it.
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Iron (Ferrous Sulfate) | 65 mg |
Alternative products
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Large-dose intravenous ferric carboxymaltose injection for iron deficiency anemia in heavy uterine bleeding: a randomized, controlled trial.
- The Effect of Parenteral or Oral Iron Supplementation on Fatigue, Sleep, Quality of Life and Restless Legs Syndrome in Iron-Deficient Blood Donors: A Secondary Analysis of the IronWoMan RCT.
- Ferric carboxymaltose vs. oral iron in the treatment of pregnant women with iron deficiency anemia: an international, open-label, randomized controlled trial (FER-ASAP).
- Effect of iron therapy on fatigue symptoms in non-anaemic iron deficient women of reproductive age- A Randomized Controlled Trial.
- Intravenous iron isomaltoside treatment of women suffering from severe fatigue after postpartum hemorrhage.
- Ferric carboxymaltose in patients with heart failure and iron deficiency.
- Marginal iron deficiency without anemia impairs aerobic adaptation among previously untrained women.
- Ferric Carboxymaltose Versus Ferrous Fumarate in Anemic Children with Inflammatory Bowel Disease: The POPEYE Randomized Controlled Clinical Trial.
- Daily iron supplementation for improving anaemia, iron status and health in menstruating women.
- Altered metabolic response of iron-depleted nonanemic women during a 15-km time trial.
- The Association Between Alopecia Areata and Iron Deficiency Anemia: A Large-Scale Population-Based Case-Control Study.
- Iron Deficiency and Nonscarring Alopecia in Women: Systematic Review and Meta-Analysis.
- Comparative Analysis of Postoperative Hair Loss and Micronutrient Deficiencies After One-Anastomosis Gastric Bypass Versus Sleeve Gastrectomy.
- Assessment of Serum Ferritin Levels in Female Patients With Telogen Effluvium.
- Diagnosis and treatment of female alopecia: Focusing on the iron deficiency-related alopecia.
- The immune response in iron-deficient children: Impaired cellular defense mechanisms with altered humoral components.
- The role of iron homeostasis in remodeling immune function and regulating inflammatory disease.
- Hepcidin--a peptide hormone at the interface of innate immunity and iron metabolism.
- Adaptive immunity and vaccination - iron in the spotlight.
- Buried Treasure: Evolutionary Perspectives on Microbial Iron Piracy.